EndObetes
Developer of endoscopically delivered, durable and reversible gastrointestinal implantable devices intended to treat obesity and Type-2 diabetes by reproducing metabolic effects of gastric bypass. Team experience includes clinical and engineering leadership and a decade of human experience with the approach.
Industries
health-care
health-diagnostics
medical
medical-device
Nr. of Employees
small (1-50)
EndObetes
161 Fort Washington Avenue Suite 524 New York, NY 10032 USA
Patents
Products
Endoscopic implantable gastrointestinal device (prototype)
Prototype device delivered endoscopically designed to provide stable, reversible fixation in the GI tract and to route undigested food to the small bowel to induce metabolic effects associated with gastric bypass.
Endoscopic implantable gastrointestinal device (prototype)
Prototype device delivered endoscopically designed to provide stable, reversible fixation in the GI tract and to route undigested food to the small bowel to induce metabolic effects associated with gastric bypass.
Expertise Areas
- Endoscopic device development
- Minimally invasive metabolic therapy
- Gastrointestinal fixation technologies
- Clinical evaluation of medical devices
Key Technologies
- Endoscopic delivery systems
- Implantable gastrointestinal devices
- Mechanical fixation systems for GI tract
- Small-bowel diversion therapeutic mechanism